Clinical Trial to investigate the potential benefits of treating Actinic Keratosis with Adtec SteriPlas plasma technology.
Adtec Europe today announces the launch of a clinical trial to evaluate the change of the cutaneous microbiome in correlation to the efficacy of SteriPlas plasma technology compared to standard treatments on patients with Actinic Keratosis.
